NovoCure’s Tumor Treating Fields Help Mesothelioma Patients Live Longer In STELLAR Trial

New results from the Phase II STELLAR trial shows Tumor Treating Fields therapy in conjunction with chemotherapy extends survival in previously untreated mesothelioma patients with no safety problems.

Mesothelial Cell
• Source: shutterstock.com

More from Clinical Trials

More from R&D